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Abstract
Background: Obesity and metabolic syndrome results from a complex interaction between genetic and environmental
factors. In addition to brain-regulated processes, recent genome wide association studies have indicated that genes highly
expressed in adipose tissue affect the distribution and function of fat and thus contribute to obesity. Using a stratified
transcriptome gene enrichment approach we attempted to identify adipose tissue-specific obesity genes in the unique
polygenic Fat (F) mouse strain generated by selective breeding over 60 generations for divergent adiposity from a
comparator Lean (L) strain.
Results: To enrich for adipose tissue obesity genes a ‘snap-shot’ pooled-sample transcriptome comparison of key fat depots
and non adipose tissues (muscle, liver, kidney) was performed. Known obesity quantitative trait loci (QTL) information for
the model allowed us to further filter genes for increased likelihood of being causal or secondary for obesity. This
successfully identified several genes previously linked to obesity (C1qr1, and Np3r) as positional QTL candidate genes
elevated specifically in F line adipose tissue. A number of novel obesity candidate genes were also identified (Thbs1,
Ppp1r3d, Tmepai, Trp53inp2, Ttc7b, Tuba1a, Fgf13, Fmr) that have inferred roles in fat cell function. Quantitative microarray
analysis was then applied to the most phenotypically divergent adipose depot after exaggerating F and L strain differences
with chronic high fat feeding which revealed a distinct gene expression profile of line, fat depot and diet-responsive
inflammatory, angiogenic and metabolic pathways. Selected candidate genes Npr3 and Thbs1, as well as Gys2, a non-QTL
gene that otherwise passed our enrichment criteria were characterised, revealing novel functional effects consistent with a
contribution to obesity.
Conclusions: A focussed candidate gene enrichment strategy in the unique F and L model has identified novel adipose
tissue-enriched genes contributing to obesity.
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Introduction
Obesity and its co-associated metabolic diseases result from a
complex interaction between environmental and genetic factors
[1–3]. The polygenic Fat (F) and Lean (L) mouse models were
selectively bred for divergent body fat mass [4] and thus model
complex polygenic human obesity. Four major obesity QTLs in the
F line were initially described in an F2 cross of the out-bred F and L
mouse lines [5]. Notably, obesity in the F line is independent of
leptin,the leptinreceptorand othercharacterised single gene obesity
mutations relating to central control of appetite or energy balance
[5,6]. Indeed, F mice have a lower caloric intake than L mice [6,7].
Since the divergent adiposity of the model was selected using fat pad
mass rather than food intake, and because several studies, including
recent meta-genome wide association, link lipid metabolism and
intrinsic molecular pathways within the adipose tissue to fat mass
regulation [8–12] we reasoned that the F and L adipose tissue would
be a rich resource for identifying obesity-susceptibility genes.
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e23944We describe a stratified microarray analysis of gene expression
using first a qualitative, comparative ‘snap-shot’ pooled transcrip-
tomic approach across several adipose tissue depots and non-
adipose metabolic tissues to broadly identify adipose tissue-specific
gene expression differences between F and L lines. We used
previously defined QTL information [5] to enrich for genes with an
increased causal likelihood. This was followed by quantitative gene
chip validation in subcutaneous fat, where the largest divergence in
fat mass in response to chronic high fat (HF) feeding was observed
[13]. Havingdefined adipose-tissuespecific pathways and positional
candidate obesity genes we performed real time PCR (RT-PCR)
validation of key affected pathways. We then functionally linkedtwo
of the QTL-associated candidate obesity genes – and one non-QTL
associated gene that had an expression profile parallel to that of the
candidate genes – to fat cell function.
Results and Discussion
Insights into adipose tissue and depot-specificity of gene
expression: Snap-shot results
We applied a 4 step filtering strategy to narrow our search for
key adipose-specific obesity-associated genes (Figure 1) as de-
scribed in Methods and Materials.
The number of genes that were differentially expressed between
the lines across any of the three fat depots (3WATs) was markedly
reduced after the first filter was applied to enrich for genes co-
ordinately regulated in 3WATs (Table 1, Figure 1). Notably, in
terms of overall adiposity (3 WATs) there were 10 times as many
genes elevated in F (102) than L mice (9). This may reflect that
causal gene variants raising the upper set-point of body fat mass are
notasstronglyproscribed,intheabsenceofpredation, incontrastto
genes conferring a potentially threatening low fat mass [14]. Despite
EPI fat being the sole selection criteria for the first 20 generations of
the breeding [4] there were fewer differences in gene expression in
the EPI of F mice (380 versus SC 426 and MES 450). This may
reflect the induction of secondary inflammatory, metabolic,
angiogenic and tissue remodelling programmes that are more
pronounced in the F line SC and MES adipose tissues (see below).
This is also consistent with the SC being the most divergently HF
responsive tissue [13] and with visceral (MES) fat being highly
vascularised and immune cell-rich. In contrast, twice as many
differentially expressed genes were elevated in the EPI of L mice
(484 versus SC 262 and MES 201) which may reflect an EPI depot-
selective process that is relatively quiescent in other L fat depots.
The genes found by the relaxed 3WAT criteria were exported to
Webgestalt and screened against the Kyoto Encyclopaedia of Genes
and Genomes (KEGG) and Gene Ontology database to look for
enrichment of functional pathways that were over-represented in
the F adipose tissue (Table 2). Database for Annotation, Visuali-
zation and Integrated Discovery (DAVID) was also used for
pathway analysis with similar findings (data not shown).
Table 3 shows the list of genes identified from more stringent
criteria ($2-fold difference between the lines in 3WATs) that were
additionally positioned within major QTL boundaries [5]. This
further reduced the chance of selecting functionally neutral or
secondary genes. Three of these genes (C1qr1, Np3r and Thbs1) have
been previously linked to obesity or adipose tissue function
(Table 3). Several novel adipose-tissue specific mechanisms
potentially contributing to fat mass accumulation and/or its
associated metabolic consequences are inferred from functions
ascribed to the other genes or closely-related functionally
characterised genes or disease processes (Table 3).
‘Snap-shot’ filters for non-adipose specific divergently
expressed genes
The base population for the F and L strains was created by
crossing two inbred and one out-bred strain [4]. Line-specific
Figure 1. A stratified transcriptomics approach for adipose
tissue-specific gene enrichment. Schematic of the experimental
design used to enrich for adipose tissue- genes candidate obesity
genes. Several successive filters were applied that decreased the
numbers of genes fulfilling the inclusion criteria (right hand panel).
From top to bottom; 1. differential gene expression (.1.5-fold)
between the lines across all adipose tissues was analysed with a
‘snap-shot’ pooled transcriptomics approach. 2. Adipose selective gene
expression was then considered by including only genes that were co-
ordinately differentially expressed between the lines in the 3 white fat
depots. 3. Increased stringency ($2-fold difference) and filtering with
known obesity QTL boundaries [5] were used to select for an increased
likelihood that the differentially expressed genes were causal for
divergent adiposity. 4. A gene-environment interaction was modelled
by identifying genes that were differentially expressed in a quantitative
microarray (QM) analysis of the subcutaneous adipose tissue after high
fat feeding. Some genes fulfilling all or most of these criteria were
validated.
doi:10.1371/journal.pone.0023944.g001
Table 1. Gene numbers associated with differential
expression in adipose and grouped for QTL position.
number of total/known* genes matching criteria
FAT genes Genomewide Fob1 (%) Fob2 (%) Fob3(%) Fob4(%)
q SC 426/355 22/21 (6) 9/82) 11/11(3) 11/10(3)
q EPI 380/319 20/17 (5) 12/10(3) 9/8(3) 12/12(4)
q MES 450/378 28/25 (7) 9/9(2) 13/12(3) 8/7(2)
q3 WATsF 102/89 7/7(8) 3/3(3) 1/1(1) 1/1(1)
LEAN genes
q SC 262/228 8/7(3) 4/3(1) 7/6(3) 4/4(2)
q EPI 484/402 12/12(3) 18/13(3) 16/12(3) 19/16(4)
q MES 201/177 4/4(2) 6/4(2) 6/5(3) 7/6(3)
q3 WATsL 9/9 0/0( ) 0/0( ) 1/1(11) 0/0( )
Number of genes expressed .1.5-fold between the F and L lines in 3 distinct
white adipose depots when fold-changes in muscle, liver and kidney were set
to be between ,1.5-fold different between F and L lines. The number of genes
co-ordinately regulated in all 3 white fat depots (3 WAT) reduces the number of
genes to those with a broad functional role (not depot-specific) in fat cell
function (see text). FAT genes refer to genes with expression higher in F-line
adipose tissue and LEAN genes refer to genes with expression higher in L-line
adipose tissue. q=increased expression, Q=decreased expression. The
number after the/oblique in blue refers identified Entrez ID genes. The number
in parenthesis indicates the number of genes within a QTL [5] as a percentage
of the whole (genome wide column).
doi:10.1371/journal.pone.0023944.t001
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adiposity (neutral) may therefore co-segregate with QTLs in an F2
cross or are secondary due to vast differences in final phenotype/
pathology between the lines. Differential expression due to
sequence divergence between F and L genomes may also result
in false-positive expression differences due to altered microarray
hybridisation efficiency. To help address this, the ‘snap-shot’
analysis was used to exclude genes that were differentially
expressed across all tissues. Thus, gene expression was compared
between 3 representative adipose depots versus muscle, liver and
kidney using tissues pooled from 3 mice from each line as
described in Materials and Methods. Examples of divergently
expressed, but non-adipose-specific, genes (Depdc6 [15,16], Gsn,
Table 4) were not further pursued in the present study, although
we do not discount their potential functional relevance to the
phenotype of F or L lines [17].
Modelling a gene-by-diet interaction: further insight from
quantitative microarray
To model a gene-by-diet interaction and potentially amplify
responses of obesity-susceptibility genes we performed quantita-
tive analysis (n=4 per group) of the transcriptome in the SC fat
depot. SC fat was chosen as it showed the greatest phenotypic
divergence (fat mass) in response [13] to the obesigenic stimulus
of chronic HF feeding (Figure 2, Table 5). Notably, with the
statistical power of the quantitative microarray, far fewer genes
were differentially expressed in subcutaneous fat between the
lines under control conditions (Table 1) demonstrating the
importance of the quantitative approach for reducing false
positives. The baseline gene expression differences were clearly
amplified by diet (Table 5). As with basal differences between the
lines, the F line had a more marked gene expression response to
the diet than the L line (Figure 2, Table 5). The top functional
pathways affected in F line obesity are listed in Table 2 and
reflect an accentuation of changes in angiogenesis, cell migration,
UDP-glycosylation, prostaglandin synthesis, triglyceride and
glycogen synthesis, collagen formation, ER and stress fibre
pathways and membrane peptidases.
Validation of key changes in gene expression within the
context adipose tissue dysfunction in obesity
Line differences in key genes involved in the inflammatory
(Figure 3), metabolic and anti-oxidant (Figure 4) and hypoxia/
angiogenic (Figure 5) pathways were validated by RT-PCR in a
larger cohort (n=8–11). This gave insight into line and diet-
specific regulation of key genes contributing to obesity and the
Table 2. Gene set enrichment analyses of ‘snapshot’ and quantitative array data.
Database Category Observed number Expected Number P-Value
Upregulated 3WAT (368 genes)
GOBP fat cell differentiation 8 1 0.002
GOBP cell adhesion 22 7 0.002
GOBP cell death 26 11 0.007
GOBP cell-matrix adhesion 6 1 0.007
KEGG ECM-receptor interaction 10 1 2e-6
KEGG PPAR signaling pathway 6 1 0.005
Downregulated 3WAT (113 genes)
GOBP antigen processing and presentation of peptide antigen 5 ,1 0.0001
GOBP immune response 11 2 0.0005
KEGG Antigen processing and presentation 4 ,1 0.0008
Upregulated 3WAT not regulated in liver, muscle, kidney (165 genes)
GOBP cell adhesion 13 4 0.05
KEGG ECM-receptor interaction 7 ,11 e - 5
Downregulated 3WAT not regulated in liver, muscle, kidney (14 genes)
No significant enrichment
Database Category Observed number Expected Number P-Value
Upregulated FFvFC (350 genes) in the quantitative array
GOBP Lipid metabolic process 40 12 2e-8
GOBP Cell adhesion 31 10 4e-6
KEGG PPAR signaling pathway 9 1 2e-5
KEGG Glycerophospholipid metabolism 8 1 0.0001
Downregulated FFvFC (39 genes) in the quantitative array
GOBP Immunoglobulin mediated immune response 3 ,1 0.048
KEGG Hematopoietic cell lineage 4 ,1 6e-5
In the snapshot data, enriched categories are shown for genes differentially expressed in all three white adipose tissues (3WAT; .2-fold; .100AU in higher expressing
strain) between fat and lean mice. In the quantitative array data, enriched categories are shown for genes differentially expressed between Fat mice on a high fat diet
and Fat mice on a control diet (.2-fold; p-value,0.05, .100AU in higher condition). GOBP=Gene Ontology Biological Process; KEGG=Kyoto Encyclopedia of Genes
and Genomes pathway database. Data analysed in Webgestalt, similar results using DAVID and Metacore (not shown).
doi:10.1371/journal.pone.0023944.t002
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phenotypically divergent fat depot.
Line and diet effects on inflammatory genes
Our analyses revealed a clear line divergence of inflammatory
gene expression with distinct and sometimes unexpected HF diet
responses. Most of the genes in this pathway were not obesity
QTL-associated and hence represent secondary responses (Figure 3
and microarrays). Many inflammatory genes that were more
highly expressed in F adipose tissue have been linked with obesity
and/or insulin resistance, (Ccl3/MIP1a ´ [18] C3ar1 [19], Ccl2/
MCP1 [20], spp1/osteopontin [21]). Others appear to link obesity
and inflammation with vascular function and haemostasis (Ptgds2,
Tbaxs1, and Pla2g7 [note Pla2g16 has been linked with obesity ref.
10], Tlr13). Surprisingly, Tlr13 (mapping to Fob4) expression, but
not the Tlr2 or Tlr4 genes encoding the canonical proinflamma-
tory bacterial lipotoxin receptors (e.g. lipopolysaccharide) recently
shown to mediate adipocyte pro-inflammatory and insulin
Table 3. Genes with increased causal likelihood as indicated by a stringent stratified criteria.
Up in F line adipose tissue
Gene (Mean fold-
expression difference
across 3 WATs)
function(s)?(gene functions abridged from iHOP: http://www.ihop-
net.org). Some functions are inferred from associated phenotypes
and are denoted by (?)
Linked with obesity? (mean
expression intensity across 3WAT
‘snap-shot’ arbitrary units) [Refs]
Fob1
Thbs1 (3.4) Angiogenesis, platelet and macrophage function, fibrogenesis Yes(,402) [39–42]
C1qr1 (2) Mac/NK cell phagocytosis, lectin binding Yes (,300a.u.) [19]
Ppp1r3d (2.5) Regulatory subunit of phosphatase1, glycogen synthesis. There
are ,16 Ppp1rs
No (,100a.u.) [61: Ppp1r3a]
Tmepai (4) Transmembrane egf/androgen response, cell cycle. Obesity and androgen
signalling (?)
No(,390a.u.) [62]
Trp53inp2 (3)
embryogenesis: neural tissue, p53-inducible
No(,3060a.u.) [63]
Fob2
Ttc7b (2.5) Unknown. Related WD40/tetracopeptide involved in lipid storage(?) No(,560a.u.) [64]
Tuba1a (2) cytoskeleton/structural/transportlipid droplet-associated No(,4265a.u.) [65]
Fob3
Npr3 (7) Natriuretic peptide clearance receptor Yes(,560a.u.) [36–37]
Fob4
Fgf13 (8) morphogenesis, tissue repair. Other Fgfs have a role in adipose
tissue and metabolism?
No (,425a.u.) [66–67]
Fmr1(4.5) cell signalling, RNA binding, neuronal: Related to Prader-Willi –like
obesity syndrome in fragile X syndrome?
No(,1485a.u.) [68–69]
A stringent search, based on QTL boundaries (Horvat et al., 2000, ref 5) produces a limited set of genes with $2fold increased expression levels in all 3W A T sof F when
the difference in gene expression is set between 22a n d+2 in muscle, liver and kidney. Only genes with a higher mean intensity of 100 a.u. in the 3 WATS were selected
(more likely to be of functional relevance in adipose tissue).
doi:10.1371/journal.pone.0023944.t003
Table 4. Exclusion of non-adipose-specific (all-tissue) divergently expressed genes.
Depdc6 F-line gene expression
SC EPI MES LIV MUSCLE KIDNEY
Fat 1392 1506 947 791 888 263
Lean 10 11 14 18 12 12
fold-change 138 133 68 44 75 23
Gsn L-line gene expression
SC EPI MES LIV MUSCLE KIDNEY
F a t1 0 6699 6
Lean 8455 10420 4408 51 444 227
fold-change 2864 21646 2613 26 2444 241
Numbers represent absolute chip expression intensity (AU) values from pooled transcriptome Genechip 2.0 array of subcutaneous (SC) epididymal (EPI) mesenteric
(MES) and liver, muscle and kidney. Note, due to the mean expression intensity being ,100 AU, Depdc6 and Gsn are effectively switched on in the Fat and Lean line
tissues, respectively. Positive fold-change numbers indicate elevated in F line. Negative Ratio numbers indicate elevated in L line.
doi:10.1371/journal.pone.0023944.t004
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tissue. Tlr13 is most closely related to Tlr3 that modulates innate
immune responses [23] and, unlike TLRs1-9 [24], has not been
linked to adipose tissue biology. Of note, Tlr13 mRNA expression
is higher in extreme obesity/diabetes mouse strains (Supplemen-
tary Figure S1). Notably, some immunomodulatory genes were
expressed more highly in L adipose tissue indicating an alternate
inflammatory response (Ccl5/RANTES [25]).
Striking diet-sensitive gene expression patterns were also
observed. For example, mRNA levels for Cr2 (CD21) and Ccl19
(MIP3b) that link innate and adaptive immunity and dendritic cell
migration [26] were markedly suppressed by HF diet in the F line.
In contrast, HF diet induced proinflammatory Ptger3 expression in
F adipose tissue but suppressed obesity-associated [27] serum
proinflammatory Saa3 expression. The divergence in discrete
immune responses may help identify pathological versus reparative
processes and informs the simplistic view of a general increase in
inflammatory gene expression in adipose tissue in obesity.
Overall we saw evidence of a selectively activated proinflam-
matory adipose environment which is modulated by HF diet in F
adipose tissue but also an anti-inflammatory profile in adipose
tissue of obesity-resistant L mice with very little response to HF
diet.
Line and diet effects on metabolic genes
We found a major divergence in gene expression for lipid and
carbohydrate metabolism (Figure 4 and microarray). Genes
involved in fat oxidation (Cpt1) and energy dissipation (Ucp2) were
Figure 2. Differential gene expression in subcutaneous adipose tissues of Fat and Lean mice exposed to control or high fat diets. A.
Log (base 2) ratios of gene expression intensities in fat and lean mice on the high fat and control diets. The y-axis shows the comparison of fat and
lean strains regardless of diet. The x-axis compares high fat and control diets regardless of strain. Red spots represent genes that are significantly
differentially expressed in Fat mice on high fat diet compared to control diet. Several genes of interest with higher expression in Fat mice and on a
high fat diet are marked and labelled. B. and C. Log (base 2) gene expression intensities in (B) Fat mice and (C) Lean mice on the high fat and control
diets. For each strain, the y-axis shows the log2 expression in high fat fed mice. The x-axis is for control diet. Red spots represent genes that are
significantly differentially expressed in high fat diet compared to control diet for each strain. Several genes of interest discussed in the text are
marked and labelled on graphs for both strains. Genes expressed below the arbitrary threshold (100) throughout the experiment were removed for
clarity.
doi:10.1371/journal.pone.0023944.g002
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with HF diet. Of note, uncoupling protein 1 (Ucp1) – a major
mitochondrial protein linked to energy expenditure and obesity-
resistance [28] – was down regulated with HF in L adipose tissue,
indicating that healthy leanness was not due to increased
thermogenic drive in WAT. However, increased mRNA levels
for the lipolytic b3-adrenergic receptor (Adrb3) (quantitative
microarray data) suggests increased release of adipocyte fatty
acids, consistent with reduced adiposity which, in combination
with increased skeletal muscle fat oxidation in the L line [29], is
consistent with healthy leanness. The secreted retinol binding
protein4 (Rbp4) – associated with obesity and insulin resistance
[30] – was unexpectedly higher in L adipose tissue (Figure 4),
although it was HF-inducible in the F line. Rbp4 may therefore
have a context dependent relationship with insulin sensitivity.
Intriguingly, intracellular Rbp7 was elevated in F adipose tissue
and was further induced with HF. Rbp7 thus represents a novel
obesity-induced gene. Altered retinol metabolism appears to be a
feature of adipose tissue in obesity [9]. Lower mRNA levels of the
HDL-associated anti-oxidant factor Pon1 [31] were found in F
adipose tissue. HF diet suppressed Pon1 further in F adipose tissue
but induced Pon1 expression in the L adipose tissue (Figure 4)
suggesting an enhanced anti-oxidant response in L adipose
associates with their improved metabolic profile.
Consistent with impaired carbohydrate metabolism, pyruvate
dehydrogenase kinase 4 (Pdk4) mRNA levels – encoding a protein
that inactivatespyruvate dehydrogenaseandhencetheinitialstep in
mitochondrial(glycolysis to citrate cycle)oxidation– washigherin F
adipose tissue (Figure 4). Indeed, Pdk4 was higher across all 3WATs
in F adipose tissue (3WAT averaged mean intensity fold-change:
2.6) but not in liver muscle or kidney, exemplifying a secondary
(non-QTL) but adipose-specific change in adipose tissue interme-
diary metabolism. Ldh2 encoding lactate dehydrogenase (pyruvate
to lactate for de novo lipogenesis) showed a similar a 3WAT-specific
increase (mean intensity fold-change of ,5) in F adipose tissue,
consistent with a major, though likely secondary role for genes of
intermediary metabolism in the development of obesity.
Line and Diet Effects on angiogenic/hypoxia genes
Key changes were observed in the angiogenesis pathway
(Angpt1, Angptl4 and Anglr1, Hif1a, Apln, Il8) in F adipose tissue
(Figure 5 and microarray) consistent with adipose tissue hypoxia
being an early molecular link between obesity and insulin
resistance [32–34]. Distinct matrix metalloproteases associated
with the remodelling of adipose tissue [35] were selectively
elevated in F (Mmp3, Mmp12)o rL( Mmp9) adipose tissue (Figure 5
and microarray). Thus, alternate inflammatory, angiogenic and
adipose remodelling mechanisms are active in the two lines that
may impact upon the severity of metabolic disease.
Functional validation of key divergently expressed genes
To further validate our stratified obesity gene enrichment
approach we investigated the functional impact of 3 genes
implicated in F-line obesity on fat cell function. We chose
natriuretic peptide receptor C (Npr3), a gene associated with the
Fob3b QTL (Figure 6) and thrombospondin-1 (Thbs1; Figure 7) a
Fob1 QTL-associated gene as candidates that had passed all the
selection criteria. We also investigated one non-QTL associated
gene, glycogen synthase 2 (Gys2; Figure 8) as it had passed all but
one (within QTL) of our stringent adipose enrichment criteria.
Although more likely a secondary gene response, the conspicu-
ously large fold-change (15, versus 6 and 4 for Npr3 and Thbs1,
respectively), supporting evidence from functionally related gene
expression changes (Pdk4, Ldh2) and the additional possibility that
Gys2 may fall within an un-characterised minor QTL, we wished
to maintain scientific balance in our approach by including it.
Investigation of Npr3 uncovers of a novel role for the
ANP system in rodent lipolysis in vivo
Natriuretic peptide receptors (NPRs) regulate blood pressure
and are particularly relevant to exercise-induced lipid mobilisa-
tion [36]. The receptor encoded by Npr3 is a signalling deficient
isoform, highly expressed in adipose tissue and kidney which is
involved in clearance of active atrial natriuretic peptide (ANP).
Table 5. Quantitative gene-chip analysis results showing the numbers of genes differentially expressed .2 fold with an adjusted
p=value,0.05, and where the mean expression is .100 a.u. intensity for the higher group.
number of upregulated genes matching criteria
Genomewide Fob1 (%) Fob2 (%) Fob3(%) Fob4(%)
FC vs LC 98 3(3) 0(0) 0(0) 5(5)
FF vs LF 254 13(5) 4(2) 3(1) 12(4)
FF vs FC 95 4(4) 0(0) 2(2) 5(5)
LF vs LC 27 0(0) 0(0) 2(7) 3 (1)
number of downregulated genes matching criteria
Genomewide Fob1 (%) Fob2 (%) Fob3(%) Fob4(%)
FC vs LC 87 7(8) 2(2) 1(1) 2(2)
FF vs LF 225 6(3) 2(1) 5(2) 7(3)
FF vs FC 21 0(0) 0(0) 1(5) 1(5)
LF vs LC 16 1(6) 0(0) 2(13) 0(0)
Upregulated (A) refers to genes that are higher in the first group in the row compared to (vs) the second group in the row. Downregulated (B) refers to genes that are
lower in the first group in the row compared to (vs) the second group in the row. For example upregulated in FC vs LC means higher expression in Fat line Control fed
than in (vs) Lean line Control fed. Only diet based (high fat v control diet) and strain based (Fat v Lean) comparisons are shown. All results are from the subcutaneous fat
pad that showed the most divergent response to high fat (HF) feeding. FC; Fat line control diet, FF; Fat line HF diet, LC; Lean line control diet, LF; Lean line HF diet. The
left column shows the total number of differentially expressed genes (Genome wide) and then those that lie within the 95% confidence interval of the major QTLs
Fobs1-4 [5]. This number is also expressed as a percentage of the Genome wide number (%) in parentheses.
doi:10.1371/journal.pone.0023944.t005
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array and in the quantitative array (Figure 6A–B). RT-PCR
validation showed that Npr3 expression (Fig. 6C) closely followed
the changes in subcutaneous adipose tissue mass in response to HF
feeding in F and L mice (Figure 6D) and showed a trend towards
being increased in 4 week HF-fed C57BL/6J mice (Figure 6E).
ANP was shown to induce lipolysis in primate, but not rodent,
adipocytes through activation of the NPRA (Npr1) [37]. We
investigated the effects of the NPR3-selective agonist cyclic
ANP (cANP) on lipolysis in vivo by implanting cANP-releasing
minipumps into C57BL/6J mice, a standard model of high fat-diet
induced obesity. Plasma ANP levels were elevated in cANP-treated
mice (saline, fed state: 1763 ng/ml versus cANP infusion, fed
state: 125621 ng/ml, P,0.001), as expected from its blockade of
Npr3-mediated ANP clearance [38]. This did not affect body
weight gain with short-term (4 week) HF feeding (data not shown).
To test if the ANP system might be involved adipocyte lipolysis we
challenged the mice with a 24 hour fast during week 3 of the HF
experiment. Fasting glucose levels were in the normal range for
loss of an overnight feeding bout (saline treated: 6.160.4 mmol/L,
cANP treated: 5.860.2 mmol/L). We found a novel effect of
fasting to elevate endogenous ANP levels. This was exaggerated in
cANP-infused mice (saline fasted state: 61611 ng/ml, cANP
fasted state: 436654 ng/ml, P,0.001). In addition, cANP-treated
mice showed a significant increase in fasting NEFA levels that was
not apparent in the fed state (Figure 6F). Our data suggest that
fasting is permissive for a physiological lipolytic effect of ANP in
rodents which is exaggerated by blocking ANP clearance with
cANP in vivo. High NPR3 levels in adipose tissue of Fat mice may
abrogate the lipolytic effect of ANP locally through increased
clearance of lipolytic ANP and thus contribute to obesity. The
lipolytic effect of ANP may only be manifest in states of low insulin
action such as fasting or, perhaps more relevant, in combination
with other factors (eg obesity) that contribute to pre-existing insulin
resistance [13].
Functional insight into a novel obesigenic role for
elevated Thbs1 on adipocytes
Control of vascular growth during adipose tissue expansion is a
major regulator of adiposity [39]. We noted that a number of
genes in the angiogenic/angiostatic cascade were differentially
expressed between the F and L lines (Figure 5 and microarray).
Thrombospondin1 (Thbs1) was elevated across the three fat depots
in the snap-shot analysis and this was confirmed in the quantitative
microarray (Figure 7 A–B). Thbs1 is positioned in the Fob1 QTL
[5]. During the course of validation of this array work, others
published [40] that thromobospondin-1 was elevated in obesity
Figure 3. RT-PCR validation of inflammatory genes differentially expressed in the subcutaneous adipose tissue of Fat and Lean
mice. Fat and Lean mice were fed control (FC; black bars, LC; grey bars) or high fat diet (FF; black hatched bars, LF; grey hatched bars) for 18 weeks.
RNA was extracted and the gene specified above the graphs was measured by RT-PCR. Target gene expression was corrected to the expression level
of the housekeeping gene tata-binding protein (TBP) and is expressed arbitrarily as an adjusted ratio. *=P,0.05, **=P,0.01 significant effect of diet
within a line. {{{=P,0.001 significant difference between lines.
doi:10.1371/journal.pone.0023944.g003
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realtime PCR analysis did not show any Thbs1 change in L adipose
tissue (not validated) the increase of Thbs1 in F mice was validated
(Fig. 7C). Thbs1 mRNA was also elevated in adipose tissue from
HF-induced- and genetically-obese mice (Figure 7D–E). Critically,
the angiostatic peptide fragment [41] of thrombospondin-1 (ABT-
510) had distinct concentration-dependent effects, reducing fatty
acid uptake into 3T3-L1 adipocytes in vitro at low concentrations
(0.1–1 nM) but increasing fatty acid uptake at high physiological
(100 nM) concentrations (Figure 7F). Our data suggest Throm-
bospondin-1 may have a dual effect. In the adipose vasculature it
may curtail angiogenesis [41] and potentially prevent fatty acid
uptake through its CD36 cell surface receptor [42] at low
concentrations. However, at high concentrations thrombospon-
din-1 may have a direct hypertrophic effect on adipocyte lipid
accumulation thus promoting obesity.
Elevated Gys2 is associated with abnormal carbohydrate
metabolism and increased glycogen deposition in
adipose tissue
Despite not being positioned within any of the 4 major QTLs,
Gys2 gene mRNA was markedly higher (,14-fold) selectively in F
adipose tissues in the snap-shot experiment and this was confirmed
with the quantitative microarray and RT-PCR validation
(Figure 8A–C). Glycogen content was also elevated in the F adipose
tissue and in Lep
ob mice, a monogenic model of morbid obesity
(Fig. 8D) suggesting ectopic glycogen is a feature or adipose tissue in
obesity. Notably, mRNA levels of the regulatory subunit of
phosphatase 1 (Ppp1r3d) that targets glycogen synthase is one of
the novel Fob1 obesity candidate genes (Table 3). This finding is
consistent with a switch in intermediary metabolism from
carbohydrate oxidation (eg Pdk4) to inefficient lipid oxidation which
leads to a net increase in lipid synthesis (eg Ldh2;l a c t a t e ,d r i v i n g
glyceroneogenesis) and ectopic carbohydrate storage in adipose
tissue. Ofnote,glycogencomplexeswithwater and thus hasa higher
mass per mole than lipid. Ectopicglycogen deposition may therefore
make an important contribution to fat pad mass per unit stored.
Conclusions
We have gained insight into metabolic, inflammatory and
angiogenic remodelling responses characteristic of obesity, some of
which overlap with those described by others [43–45] and that are
consistent with broad changes found in microarray studies on
adipose tissue from obese rodents and humans [46–52]. Crucially,
some of our observations are unique to our model. This is very
likely due to the polygenic nature and unique selection-based
Figure 4. RT-PCR validation of metabolic and anti-oxidant genes differentially expressed in the subcutaneous adipose tissue of Fat
and Lean mice. Fat and Lean mice were fed control (FC; black bars, LC; grey bars) or high fat diet (FF; black hatched bars, LF; grey hatched bars) for
18 weeks. RNA was extracted and the gene specified above the graphs was measured by RT-PCR. Target gene expression was corrected to the
expression level of the housekeeping gene tata-binding protein (TBP) and is expressed arbitrarily as an adjusted ratio. *=P,0.05, ***=P,0.001
significant effect of diet within a line. {=P,0.05, {{=P,0.01, {{{=P,0.001 significant difference between lines.
doi:10.1371/journal.pone.0023944.g004
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leanness)-related changes beyond other commonly used models (eg
monogenic Lep
ob or HF-fed C57BL/6J), with relevance to human
obesity and its associated metabolic disturbances. Devising a
stratified systems approach integrating gene expression, tissue-
specific, depot-specific and functional data with positional (QTL)
information allowed a more rigorous test to identify and validate
candidate obesity genes. We have been able to show that a prime
obesity candidate gene (Npr3), that fulfilled all the required criteria,
turned out to have a complex, context-dependent effect on fat
mobilisation in mice in vivo. Npr3 may also link obesity-related
hypertension [13] in the model. Our approach has led to
identification of a novel direct effect of thrombospondin-1 on fat
cell hypertrophy. The exact mechanism whereby Thbs1 promotes
obesity will require further study due to its complex modular
structure, functions and multiple receptors [53]. Nevertheless the
effect of the type 1 repeat of thrombospondin-1 (ABT-510) suggests
a functional cross-talk between adipose tissue endothelial cells and
fat cells. Given the success of our stratified enrichment strategy in
linking candidate genes with fat cell function we anticipate that the
other QTL-associated genes will also have direct and functionally
relevant effects on obesity. This is further emphasised (see Table 3)
by the reported (Np3r, C1qr) or inferred roles of these genes in either
fat cell function (Ttc7b, Tuba1) or obesity-associated insulin
resistance (Ppp1r3d, Trp53inp2, Fgf13, Fmr).
Our results highlight the benefit of using transcriptomics in
addition to F2 QTL information to identify secondary, adipose-
enrichedgenes(Gys2, Pdk4,Ldh2;intermediaryfatandcarbohydrate
metabolism in fat cells) in parallel with positional candidate genes.
These geneslikely contributeto obesity (egectopicglycogen storage)
and its consequences regardless of the mechanistic origin of
excessive weight gain. The original QTL mapping study [5] was
done using the outbred F and L lines and a low-density genetic
marker spacing with the power to detect only major QTL effects.
Our current study may therefore have uncovered novel minor
QTLs that were here regarded as ‘non-QTL-associated’, and so it
was important to document a prime example of at least one gene
(Gys2) that otherwise, and rather conspicuously (large fold change
across 3WATs, validated in quantitative array), passed our filtering
criteria. Potentially, Gys2 or other genes could be confirmed as true
expression (e)QTLsinfuture high resolution F2 mapping.Offurther
note, many of the inflammatory changes are non-QTL associated,
suggesting that these genes are secondary, though still important,
responders to obesity. Interestingly, there were no major expression
differencesin well-characterised transcriptional pathways regulating
adipocyte formation (C/EBPs, PPARs, GATAs, RIP140, ERRs,
Figure 5. RT-PCR validation of angiomodulatory genes differentially expressed in the subcutaneous adipose tissue of Fat and Lean
mice. Fat and Lean mice were fed control (FC; black bars, LC; grey bars) or high fat diet (FF; black hatched bars, LF; grey hatched bars) for 18 weeks.
RNA was extracted and the gene specified above the graphs was measured by RT-PCR. Target gene expression was corrected to the expression level
of the housekeeping gene tata-binding protein (TBP) and is expressed arbitrarily as an adjusted ratio. *=P,0.05 significant effect of diet within a line.
{=P,0.05, {{{=P,0.001 significant difference between lines.
doi:10.1371/journal.pone.0023944.g005
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accumulation and synthesis (SREBPs).
The L mice remarkably lose fat mass with HF feeding and may
model beneficial adipose tissue changes with weight loss [13]. After
bariatric surgery in obese patients there is a switch in gene
expression from prominent stress-related pathways to genes
consistent with remodelling of the adipose tissue [54]. L mice
show a similar response with alternate-inflammatory, adipose
remodelling and lipolytic effects alongside improved metabolic
function with HF diet [13]. Thus the gene pathways changing in L
mice losing fat mass with HF feeding are not akin to a
‘lipodystrophic’ re-distribution of calories into non-adipose tissues
with consequent worsening of metabolic disease. This data may
point to important leanness genes that act independently in
adipose tissue to help cope with cellular stress and this is an area of
important future investigation.
Future work in the adipose tissues of refined congenic lines with
discrete QTLs introgressed on the comparator genetic background
will help apply additional filters for gene expression and functional
characterisation of candidate adiposity genes. This approach has
been successful in identifying Pc2 as an important obesity
candidate gene, albeit of hypothalamic origin, in a C57BL/6J
subcongenic line carrying a 7.4 Mb region of chromosome 2 from
SPRET/Ei mice [55]. A similar approach led to the positional
cloning and identification of the Prcp gene as being causal for a
hypothalamic mechanism of leanness involving a-MSH degrada-
tion [56]. An optimal test to prove that a candidate gene is causal
for the QTL effect is quantitative complementation [57], which
requires knockout models in particular genetic backgrounds.
These resources are currently unavailable for the F and L lines.
Therefore, the approach of developing novel subcongenic lines
with ever smaller donor segments combined with bioinformatics,
sequence, expression, and functional analyses remains an optimal
strategy to find causal sequence variation for obesity candidate
genes identified in this study. Recent SNP genome-wide
association studies (GWAS) in humans revealed that quantitative
variation in obesity is due to the action of numerous QTLs of
relatively small effect; each of the obesity loci detected generally
account for less than 1% of the phenotypic variance [1–2,12].
In an extremely large scale GWAS study exploring a well
characterised quantitative trait, height, the 180 loci uncovered
accounted for only 10% of phenotypic variation [58]. Quantitative
Figure 6. Validation and functional investigation of the candidate obesity gene Npr3.A .Snap-shot pooled transcriptome microarray chip
intensities (arbitrary units) across subcutaneous (SC), epididymal (EPI), mesenteric (MES) adipose tissues versus liver, muscle and kidney in Fat (F) and
Lean (L) mice with the rounded expression ratio in bold. B. Mean chip intensity from quantitative microarray (n=4) in Fat and Lean mice fed control
(FC, LC) or high fat diets (FF, LF) with relevant P value for significant differences. C. RT-PCR validation of changes in Npr3 gene expression along with
its relationship to D. Altered fat mass in response to high fat diet in subcutaneous adipose tissue of control diet-fed Fat (FC, black bars), high fat diet-
fed Fat (FF, black hatched bars), control diet-fed Lean (LC, grey bars) and high fat diet-fed Lean (LF, grey hatched bars) mice. *=P,0.05 significant
effect of diet within a line. E. Expression levels of Npr3 in subcutaneous fat of control diet (horizontal hatched bar) or HF fed (heavily stippled bar)
C57BL/6J mice (C57). F. The effects of fasting (fast) on plasma free fatty acid levels (NEFA) in C57BL/6J mice implanted with minipumps releasing
saline (S) or 100 ng/day cyclic ANP3-23 (cA). **=P,0.01 for an effect of cA treatment of fasting NEFA.
doi:10.1371/journal.pone.0023944.g006
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than initially predicted and highly statistically-powered animal
studies in defined models such us the one used here are likely to
uncover additional obesity loci that would remain undetected in
human GWAS.
The unique selection basis of the Fat and Lean strains on fat pad
mass divergence highlights some previously unidentified molecular
mechanisms contributing to fat mass accumulation and its
downstream metabolic sequelae that may be amenable to
therapeutic intervention. The genes and pathways identified by
our stratified enrichment approach may prove important over and
above the genetically determined appetitive, energy expenditure
and activity-mediated drivers of fat mass in rodents and humans.
Methods
Experimental Design
Experiment 1. ‘Snap-shot’ pooled transcriptome microa-
rray. Our first experiment was designed to look across a panel
of tissues of the F and L mice including 3 white adipose tissue
depots, liver, muscle and kidney for broad and large qualitative
fold-changes in gene expression (Figure 1). Individual tissues were
pooled from 3 chow fed mice of each line (ie 3xSC, 3xEPI,
3xMES, 3xliver, 3xmuscle and 3xkidney samples were combined
to produce representative distinct tissue RNA with reduced
biological variability in this initial step). This pooled
transcriptome approach is referred to as the ‘snap-shot’
approach. Before microarray we confirmed that previously
described changes in leptin and 11b-HSD1 expression [13] were
found in the individual adipose tissues depots of the sampled mice
by northern blot (data not shown). RNA was hybridised to
Affymetrix Genechip 2.0 arrays according to standardised
protocols at the (Ark Genomics, Roslin, UK). We again used
previously described differences in gene expression [13] as
validatory transcriptome ‘landmarks’ for the qualitative
microarray data. The snap-shot approach allowed us to 1.
Assess which genes were grossly different between the Fat and
Lean lines across all tissues tested. 2. Provide information on which
genes were divergently expressed selectively across all white
adipose depots. 3. Apply a stricter criterion for genes that were
Figure 7. Validation and functional investigation of the candidate obesity gene Thbps1.A .Snap-shot pooled transcriptome microarray
chip intensities (arbitrary units) across subcutaneous (SC), epididymal (EPI), mesenteric (MES) adipose tissues versus liver, muscle and kidney in Fat (F)
and Lean (L) mice with the rounded expression ratio in bold. B. Mean chip intensity from quantitative microarray (n=4) in Fat and Lean mice fed
control (FC, LC) or high fat diets (FF, LF) with relevant P value for significant differences. C. RT-PCR validation of changes in Thbps1 gene expression in
subcutaneous adipose tissue of control diet-fed Fat (FC, black bars), high fat diet-fed Fat (FF, black hatched bars), control diet-fed Lean (LC, grey bars)
and high fat diet-fed Lean (LF, grey hatched bars) mice. **=P,0.01 versus FC. D. Thbps1 mRNA levels in control-fed C57BL/6J (C57, horizontal striped
bars) and genetically-obese leptin-deficient Lep
ob mice (Ob, lightly stippled bars) and E. Thbps1 mRNA levels in control-fed C57BL/6J (C57, horizontal
striped bars) and high fat diet fed C57BL/6J mice (C57 HF, heavily stippled bars). *=P,0.05 versus lean control. E. The effects of the
thrombospondin-1 type 1 repeat ABT-510 (0.1–100 nM, grey bars) on
3H-palmitate uptake into fully differentiated 3T3-L1 adipocytes. **=P,0.01
versus control (Ctrl, black bar), non-ABT510 treated cells.
doi:10.1371/journal.pone.0023944.g007
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metabolic tissues to increase the likelihood of identifying adipose-
specific causal obesity genes. Note the original selection criterion
of the F and L mice was on divergent fat pad mass and that the
obesity is not the result of increased food intake [6,7]. Moreover,
this was useful since the mixed genetic background of the base
population may have carried ‘bystander’ genes that are
differentially expressed between the lines in both adipose and
non-adipose tissues, but that are not related to the divergent
obesity and metabolic phenotype. 4. Obtain information on
possible adipose tissue depot-specific changes in gene expression that
are informative as regards the impact of different fat depots on
metabolic disease.
Experiment 2. Exon-chip microarray with dietary inter-
vention: Our second experiment was designed to look at the
adipose tissue depot which showed the greatest divergence in mass
between the lines in response to chronic high fat feeding [13]. We
took subcutaneous fat from control diet and high fat fed F and L
mice after 18 weeks on the diets (n=4) which allowed us to
1.Validate changes in subcutaneous fat from experiment 1 and 2.
Perform quantitative analyses on the changes in gene expression
between the lines and identify line-specific effects of the diet.
Bioinformatics analysis of microarray data. 1. Experi-
ment 1 looked at qualitative fold changes in gene expression between
the lines in the 3 WAT depots (subcutaneous (SC), epididymal (EPI)
and mesenteric (MES), liver (L), muscle (M) and kidney (K). We set
the fold-difference threshold for changes of interest to .61.5 (where
denoted a ‘2’ refers to genes that are up regulated in the Lean line
and, positive numbers denotes genes that are up regulated in the F
lines, respectively). Initially we did not specify any range limitations for
gene expression changes in L, M or K. A second filter set the fold
change within L, M or K to be within ,61.5. This search narrowed
our targets to white adipose tissue-specific changes in gene expression,
with the caveat that many gene pathways maybe linked between or
operate differently/reciprocally from white fat and non-adipose
tissues. An example would be the opposing effects of glucocorticoids in
adipose versus liver for 11b-HSD1 expression [13]. Further, for
candidate genes we excluded all genes whose absolute signal was
below the threshold of 100 (genes unlikely to be meaningfully
expressed in the adipose) in one or both lines, with the caveat that it is
p o s s i b l es o m eg e n e sm a yb ee f f e c t i v e l ys w i t c h e do no ro f fi na d i p o s e
tissue of one or other line (eg Depdc6 and Gsn,s e et e x t ) .
2. Quantitative microarray analysis of subcutaneous fat in
experiment 2 looked at fold changes in gene expression in a single
fat depot, but allowed us to further assess the effects of chronic
high fat feeding between and within the lines. We set the fold
difference threshold to 61.5 as before.
QTL-informed analysis. Analysis of both experiment 1 and
experiment 2 benefited from the previously identified major QTL
information [5], which we introduced as a filter to provide more
information on which genes were more likely to represent causal
genes (found within the 95% confidence interval of the four major
QTL boundaries) and those which were more likely secondary (not
found within the 95% confidence interval of the four major QTLs).
Figure 8. Validation and functional investigation of the non-QTL linked, obesity-associated gene Gys2.A .Snap-shot pooled
transcriptome microarray chip intensities (arbitrary units) across subcutaneous (SC), epididymal (EPI), mesenteric (MES) adipose tissues versus liver,
muscle and kidney in Fat (F) and Lean (L) mice with the rounded expression ratio in bold. B. Mean chip intensity from quantitative microarray (n=4)
in Fat and Lean mice fed control (FC, LC) or high fat diets (FF, LF) with relevant P value for significant differences. C. RT-PCR validation of changes in
Gys2 gene expression in subcutaneous adipose tissue of control diet-fed Fat (FC, black bars), high fat diet-fed Fat (FF, black hatched bars), control
diet-fed Lean (LC, grey bars) and high fat diet-fed Lean (LF, grey hatched bars) mice. {{=P,0.01 difference between F and L lines, *=P,0.05
indicates and effect of diet within the L line. D. Glycogen content of fat pads in subcutaneous adipose tissue of control diet-fed Fat (FC), high fat diet-
fed Fat (FF), control diet-fed Lean (LC) and high fat diet-fed Lean (LF) mice and in genetically-obese leptin-deficient Lep
ob (Ob, white bars) mice.
{{=P,0.01 difference between F or Ob versus and L mice and *=P,0.05 indicates and effect of diet within Fat or Lean lines.
doi:10.1371/journal.pone.0023944.g008
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(RT-PCR) for ‘landmark’ genes on RNA from adipose tissues,
functional assessment of biochemical changes (glycogen) in the
adipose tissue of the lines and a number of in vitro and in vivo studies
to test distinct hypotheses (Natriuretic peptide receptor and
thrombospondin1).
F and L mice
Ethics Statement. All animal experiments were performed
according to local ethical guidelines of The University of Edinburgh
EthicsCommitteeand thoseofthe (ScientificProcedures)Act(1986)
of the UK Government Home Office under the auspices of an
approved Home Office Project License (60/3962).
The long-term selection and further development of the F and L
lines and details of the genetic basis of the line divergence and the
inbreeding period are described elsewhere [4–7,15–16]. Mice
derived from the inbred lines were used in this study [4]. Extensive
characterisation of our lines in previous studies determined that
body weight gain is highly correlated with fat mass accretion in fat
mice [4–7]. This was substantiated in several genetic mapping
experiments [5,15–16] demonstrating that the fat% trait and body
weight trait co-localise to the same QTL regions with significant
LOD scores. We followed bodyweight change closely and
interpreted the changes in our lines as being primarily due to
altered body fat mass. Animals were fed on pelleted Rat and Mouse
breeder and grower diet (Special Diets Services, SDS, UK Ltd.,
Witham, Essex, UK) or with defined low (11% calories as fat with
sucrose; D12329) and high fat (58% calories as fat with sucrose;
D12331) diets (Research Diets, New Brunswick, New Jersey).
Tissue and plasma measurements
At the end of the experiment, mice were killed within 1 minute of
disturbing the home cage by cervical dislocation, to avoid stress-
induced changes in metabolic parameters. Blood was collected in
EDTA coated tubes (Sarstedt, Numbrecht, Germany). Plasma
insulin was measured by ELISA (Crystalchem, Downers Grove,
IL, USA), glucose by (Infinity reagent, Sigma, Dorset, Uk) and free
fatty acids (Wako Diagnostics, Neuss, Germany) levels (FFA) were
measured with a colorimetric method. Liver (L), muscle (quadriceps,
M),kidney(K),andepididymal(E),subcutaneous(S),andmesenteric
(M) adipose tissues were collected, weighed and stored at 280uC.
RNA extraction and analysis
RNA was extracted using 800 ml TRIzol reagent (Invitrogen,
Paisley, UK) per 50 mg tissue. Briefly, 200 ml of chloroform was
added to the homogenate then centrifuged at 12,000 rpm for
1 min to remove cell debris. The supernatant was then vortexed
for 15 s and centrifuged at 12,000 rpm for 15 min at 4uC. The
upper (aqueous) layer was removed, mixed with 30 ml of RNAid+
matrix (Anachem, Luton, UK) and agitated for 5 min before
centrifugation at 12,000 rpm for 1 min. The supernatant was
removed and washed 3 times with 500 ml of RNA wash (Anachem,
Luton, UK), resuspended in 20 ml of DEPC-treated water with
10 mM DTT, 1 U/ml RNasin (Promega, Southampton, UK) and
eluted by incubation at 55uC for 10 min. Concentration and
purity of RNA was assessed using a GeneQuant RNA/DNA
calculator (GE healthcare, Amersham, UK) before northern blot
or real-time PCR analysis. For Northern blotting, 5 mg of RNA
was denatured at 65uC for 15 min in a mixture of MOPS,
deionised formamide and formaldehyde as described (Morton et
al., 2005) and run on denaturing MOPS/formaldehyde 0.8%
agarose gels. Briefly, RNA was transferred using capillary action
onto a nylon membrane for hybridisation, using 206SSC as the
transfer buffer. RNA was crosslinked by UV exposure (Spectronics
Corporation, power at 12006100 mw/cm
2). Membranes were
prehybridised at 65uC for 3 h with 18 ml of phosphate buffer and
9 ml of 20% SDS in a hybridization bottle. 1 ml of salmon testes
DNA (10 mg/ml) was denatured at 100uC for 10 min and added
to the pre-hybridization mix. Radiolabelled cDNA probes were
made for genes of interest using a rediprime2 random prime
labelling kit (GE Healthcare). 25 ng DNA template (PCR
fragment) was diluted to 45 ml with TE buffer. The probe was
then denatured at 100uC for 15 min and immediately cooled on
ice for a further 10 min. Denatured DNA was then added to the
reaction tube together with 5 mlo f[
32P]-dCTP. The reaction was
incubated at room temperature for 2 h then labelled cDNA was
purified through a Nick column (GE healthcare, Buckinghamshire
UK). The hybridization mixture was then incubated overnight at
55uC. Three 15 minute 50 ml washes were performed; an initial
wash at room temperature with 26SSC and 0.1% SDS was
followed by 2 washes at 65uC, with 16SSC, 0.1% SDS then
0.56SSC, 0.1% SDS. The washed membrane was wrapped in
Saranwrap and exposed to a phosphorimager screen (Fujifilm,
Bedford, UK) for 10 min and scanned using a Fuji BAS
phosphorimager. Transcipt levels were quantified using Aida
software (Advance image data analyzer Version 3.44.035).
Microarray analysis
For the snapshot experiment, tissue RNAs were prepared using
Qiagen RNeasy kits, processed through standard Affymetrix
protocols, and hybridized to Affymetrix Mouse Genome 430 2.0
GeneChips (n=4 per group, Affymetrix, Santa Clara). Raw CEL
file data were imported into BioConductor for background
subtraction and normalization with the Robust Multichip Average
(RMA) algorithm. Differential expression was determined using
the Bioconductor Limma tool and the Benjamini and Hochberg
FDR method. Annotation data for the genes were obtained from
NetAffx. WebGestalt (http://bioinfo.vanderbilt.edu/webgestalt,
Vanderbilt University, USA), DAVID (http://david.abcc.ncifcrf.
gov/, National Institute of Allergy and Infectious Diseases) were
used to cross validate clustering and pathways analyses. Full
microarray data are MIAME compliant and are available in the
ArrayExpress database under the accession number M-EXP-3091.
For the quantitative microarray RNA was prepared with Qiagen
RNeasy kits and hybridised to Affymetrix mouse ST 1.0 Gene-
Chips. Data were imported into the Onechannelgui package of
Bioconductor, normalised with RMA (with background subtrac-
tion) and analysed with Limma with Benjamini and Hochberg
FDR multiple testing correction. Data are available in ArrayEx-
press with accession number E-MEXP-3094. Microarray process-
ing was by the ARK Genomics team at the Roslin Institute.
Real-time PCR
cDNA was synthesised from 2 mgR N Au s i n gR e v e r s eT r a n s c r i p -
tion system (Promega, Southampton, UK) with oligo(dT) primer,
according to the manufacturer’s instructions. Gene-specific mRNA
levels were measured using the LightCyclerH 480 Real-Time PCR
system (Roche Diagnostic Ltd, West Sussex, UK) with light cycler
480 probe master (Roche Diagnostic Ltd, West Sussex, UK) and
TaqManHGeneexpressionAssays(Applera,Cheshire,UK).Samples
were analysed in triplicate with each PCR reaction containing 4.5 ml
cDNA, 5 mlm a s t e rm i xa n d0 . 5 ml primer-probe. Results are
expressed as the ratio of gene of interest corrected to the
housekeeping gene TBP mRNA levels as an internal control.
TaqManH Gene expression Assays were inventoried and are avai-
lable from the Applera website (http://www.appliedbiosystems.com/
absite/us/en/home/applications-technologies/real-time-pcr.html).
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The 3T3-L1 cell line is a preadipocyte cell line derived from the
Swiss 3T3 mouse fibroblast cell line [59] Cells were cultured in
Dulbecco’s modified Eagle medium (DMEM) (Cambrex, Verviers,
Belgium) supplemented with 10% new born calf serum (NCS),
2 mM L-glutamine, penicillin (50 U/ml) and streptomycin
(50 ug/ml) (Invitrogen, Paisley, UK) at 37uC in humidified
atmosphere with 5% CO2. Confluent 3T3-L1 cells were subjected
to differentiation protocol. Maintenance medium was changed at
day 0 to differentiation DMEM but with additional 10% FBS to
replace NCS and supplemented with 0.5 mM isobutylmethyl-
xanthine (IBMX), 0.25 mM dexamethasone (Dex), 1 ug/ml insulin
and 100 nM Rosiglitazone.
Palmitate uptake
Pre-adipocytes (passage 8–11) were seeded onto 12 well plates at
a density of 2.5610
5 cells/well. Adipocytes were then fully
differentiated with the above protocol and incubated with
charcoal-stripped fetal calf serum overnight. ABT-510 1–
100 nM (dissolved in sterile PBS) was incubated in stripped serum
with the adipocytes for 6 hours at 37uC. Palmitate uptake was
measured by the addition of unlabeled palmitate, dissolved in
ethanol, and tracer (final 200 nM) radiolabelled
[3H] palmitate
(0.3 mCi) in a 0.1% BSA solution. Cell-associated radioactivity was
obtained by counting aliquots of both the medium and in the cells
scraped with 10% SDS in 2 mls of aqueous scintillation fluid (GE
healthcare) in a Beckman LS330 scintillation counter.
Cyclic atrial natriuretic peptide (cANP) studies in vivo
13 C57/BL6J male (in house colony) at approximately 4-month
of age were used for the study. Mice were weighed and divided into
two groups to match initial body weight. Allowing for variations in
body weight, mini pumps were prepared using sterile saline or
varying amounts of cANP3-23 (Bachem, Switzerland) dissolved in
sterile saline to allow infusion of ,100 ng/day cANP3-23 a dose
chosen to cause maximal NP3R occupancy [38]. The pumps were
primed in saline and stored in the refrigerator for three days prior to
implantation. On the day of surgery, animals were fasted for
4 hours, weighed and blood samples were taken from tail nicks to
measure basal ANP, glucose and circulating FFAs. Animals were
anaesthetised with 5% isofluorane/oxygen mixture and the pumps
were inserted subcutaneously. After recovery, animals were started
on a 58 kcal% fat w/sucrose high fat diet (Research Diets). Body
weight and food consumption were measured routinely twice a
week. At week 3, a physiological challenge to elevate free fatty acids
was performed (24 hour fast) and the change in body weight
recorded to determine fat mobilisation.
Glycogen assays
Tissue glycogen was assessed using a modified acid hydrolysis
extraction protocol [60]. Briefly, 500 mL 0.03 M HCl were added
to approximately 200 mg of adipose tissue, homogenized and then
boiled for 45 min at 80–90uC in a water bath. Sample pH was
adjusted to pH 5 by adding a small amount of either 1.1 M HCl.
The samples were incubated water bath shaker at 37uC for at least
2 h. Glucose levels were determined at room temperature as
described above.
Statistical analyses
Gene expression differences in validation realtime was analysed
using 2-way ANOVA for line and diet effects followed by post-hoc
Holm-Sidak multiple comparison tests using Sigmastat version 3.5
(Systat Software Inc). Effects of treatments on biological
parameters such as fatty acids, tissue glycogen or palmitate uptake
were assessed using 1-way ANOVA. P-values below 0.05 were
accepted as statistically significant.
Supporting Information
Table S1 Selected strains with high fasting plasma glucose levels
after chronic HF feeding.
(DOC)
Figure S1 Toll-like receptor 13 (Tlr13) mRNA levels in adipose
tissues from obese diabetic mouse strains. The bars show the
relative expression of Tlr13 in the adipose tissues from multiple
strains (http://biogps.gnf.org). Tlr3 expression patterns are shown
from 2 eQTL analyses (gnf1m32524_at and 1457753_at) from the
gene expression/acitivty chart of biogps from ‘Fat’ or ‘Adipose’.
High Tlr13 expression is found in mouse strains that are also obese
and diabetic (Supplemental Table S1 [70]).
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